About PreClinOmics
PreClinOmics is a Healthcare company based in Indianapolis (United States) founded in 2001, and was acquired by Crown Bioscience in March 2016. Contract research organization (CRO) with expertise in Metabolic, Renal and Cardiovascular disease. Its focus areas include Biopharma Outsourcing, CRO, Preclinical Studies and Diversified. Its competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences; 2 of its 3 listed competitors have raised funding.
Company details
PreClinOmics was founded in 2001 as a preclinical contract research organization based in Indianapolis, United States. Operations focus on metabolic, renal, and cardiovascular disease models, with in-house breeding programs for ZDSD rats, FATZO mice, and polycystic kidney disease strains. Services encompass in-vivo studies, analytical testing, pharmacokineticsADME, and safetytoxicology for areas including obesity, diabetes, and neurology. The company has operated as a subsidiary of Crown Bioscience since March 2016.
- Headquarters Indianapolis, United States
- Stage Acquired
- SectorsHealthcare
- Website preclinomics.com
- Social LinkedIn
- Acquired by Crown Bioscience (Mar 2016)
- Latest Funding Round$1.34M (USD), Grant
Jun 2012
- InvestorsCrown Bioscience
& 1 more
- Acquired byCrown Bioscience
(Mar 2016)
Funding Insights of PreClinOmics
- Total Rounds 4
- Last Round Grant — $1.34M
- First Round $1.05M
(Dec 2005)
- Investors Count 1
All 4 funding rounds of PreClinOmics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in PreClinOmics
PreClinOmics has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Crown Bioscience and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Cancer and CVMD drugs are developed using PDX models. | 2006 | crownbio.com | Santa Clara, United States |
Investor details for PreClinOmics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PreClinOmics
4 dated milestones of PreClinOmics across 15 years, from founding to its latest funding, stage changes and deals.
- Founded PreClinOmics is founded.
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant, of $1.3M.
- Exit Acquired by Crown Bioscience.
Competitors of PreClinOmics
PreClinOmics has 3 listed competitors in our database, 2 of them funded. They include PsychoGenics, InVivo Biosystems and Noble Life Sciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| psychogenics.com | 1999 | Tarrytown, United States | 124 | Preclinical CRO services for CNS and orphan disorders are offered. | ||
| invivobiosystems.com | 2019 | United States | $8.16M | Animal models are supplied for in-vivo analytical services. | ||
| noblelifesci.com | 2010 | Woodbine, United States | $335,000 | Preclinical contract research organization offering standard GLP and non-GLP services |
Detailed competitors of PreClinOmics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PreClinOmics
Websites that share an audience with PreClinOmics (preclinomics.com).
Websites whose visitors overlap most with PreClinOmics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
kardscientific.com | kardscientific.com | 100% | – | ||
algosinc.com | algosinc.com | 99% | – | ||
insight-group.org | insight-group.org | 59% | #3,825,852 | – | |
| google.com | 40% | 85.8B | #1 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as PreClinOmics (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PreClinOmics
PreClinOmics was founded in 2001 and raised its 1st funding round 4 years after it was founded.
PreClinOmics is headquartered in Indianapolis, United States. It is registered at Indianapolis, Indiana, United States.
PreClinOmics was founded in 2001 as a preclinical contract research organization based in Indianapolis, United States. Operations focus on metabolic, renal, and cardiovascular disease models, with in-house breeding programs for ZDSD rats, FATZO mice, and polycystic kidney disease strains. Services encompass in-vivo studies, analytical testing, pharmacokineticsADME, and safetytoxicology for areas including obesity, diabetes, and neurology. The company has operated as a subsidiary of Crown Bioscience since March 2016.
PreClinOmics's top competitors include PsychoGenics, InVivo Biosystems and Noble Life Sciences.
PreClinOmics has 2 investors. Key investors include Crown Bioscience, and HHS.
Yes. PreClinOmics was acquired by Crown Bioscience in March 2016.